Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO) - A pilot study

Indian Journal of Medical Research

Volumn 140, Issue , 2014, Pages 604-608

  Khalighi, A R ^a   Khalighi, M R ^b   Behdani, R ^b   Jamali, J ^c   Khosravi, A ^a   Kouhestani, Sh ^a   Radmanesh, H ^b   Esmaeelzadeh, S ^b   Khalighi, N ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hydrogen breath test (HBT); Lactol; Small intestinal bacterial overgrowth (SIBO) syndrome

Indexed keywords

LACTOL; MINOCYCLINE; PROBIOTIC AGENT; UNCLASSIFIED DRUG; HYDROGEN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERUCTATION; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; HYDROGEN BREATH TEST; LACTOBACILLUS; MAINTENANCE THERAPY; MALE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMALL INTESTINAL BACTERIAL OVERGROWTH SYNDROME; SMALL INTESTINE DISEASE; TREATMENT RESPONSE; YOUNG ADULT; BACTERIAL INFECTIONS; BREATH ANALYSIS; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE;

ABDOMINAL PAIN; ADULT; BACTERIAL INFECTIONS; BREATH TESTS; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROGEN; INTESTINE, SMALL; MALE; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS;

EID: 84920407930     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Binder HJ. Disorders ofAbsorption. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, editors. Harrison’s principles of internal medicine. 18th ed; New York: McGraw Hill; 2012. p. 2460-76.
2. Kleigman RM, Behrman RE, Jenson HB, Stanton BF. Nelson textbook of pediatrics. 19th ed. Philadelphia: PA: Saunders; 2011.
3. Quigley EM. Bacteria: a new player in gastrointestinal motility disorders - infections, bacterial overgrowth, and probiotics. Gastroenterol Clin North Am 2007; 36: 735-48.
4. O’Mahony S, Shanhan F. Enteric microbiota and small intestinal bacterial overgrowth. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger & Fordtran’s gastrointestinal & liver disease:pathophysiology,diagnosis,management. 9th ed. Philadelphia: Saunders Elsevier; 2010. p. 1772-7.
5. Scherezenmeir J, De Verse M. Probiotics, and synbiotics- approaching a definition. Am J Clin Nutr 2001; 73: 361S-64S.
6. De Simone C, Ciardi A, Grassi A. Effect of Bifidobacterium bifidum and Lactobacillus on gut mucosa peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol 1992; 14: 331-40.
7. Fuller R. Probiotics in human medicine. Gut 1991; 32: 439-42.
8. Freter R. Factors affecting the microecology of the gut. In: Fuller R, editor. Probiotics, the scientific basis. London: Champan & Hall; 1992. p. 111-44.
9. Reid G. Probiotics for urogenital health. Nutri Clin Care 2002; 5: 3-8.
10. Rowland IR, Grasso P. Degradation of N-nitrosamines by intestinal bacteria. ApplMicrobiol 1975; 29: 7-12.
11. Semard CA, Powell DW. Approach to the patient with diarrhea and malabsorption. In: Goldman L, Ausiello DA, editors. Cecil medicine, 23th ed. Philadelphia: PA: Saunders Elsevier; 2008. p. 1029.
12. Soifer LO, Peralta D, Dima G, Besasso H. Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study. Acta Gastroenterol Latinoam 2010; 40: 323-7.
13. Barrett JS, Canale KE, Gearry RB, Irving PM, Gibson PR. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol 2008; 14: 5020-4.
14. Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs 2012; 72: 803-23.
15. Rohde CL, Bartolini V, Jones N. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea. Nutr Clin Pract 2009; 24: 33-40.
16. Bixquert Jimenez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? Revista espanola de enfermedades digestivas. Rev Esp Enferm Dig 2009; 101: 553-64.